Evidence map›Paper›PMID 42310251›Full record

ReviewAlimentary pharmacology & therapeutics2026

Review Article: Implementation Challenges in Helicobacter pylori Management: Bridging Evidence and Real-World Practice.

Duc Trong Quach, Jyh-Ming Liou, Javier P Gisbert, Wai Keung Leung, Steven F Moss, Carlo A Fallone, Peter Katelaris, Christian Schulz, Violet Kayamba, Liya Zhou and 16 more

Abstract readReview
In one paragraph

Review in Alimentary pharmacology & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Duc Trong QuachDepartment of Internal Medicine and Gastro-Hepato Integrated Research Team (GHIRT-002.TCM2025), University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0003-0141-921X
Jyh-Ming LiouDepartments of Internal Medicine and Medical Research, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-7945-5408
Javier P GisbertGastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.ORCID https://orcid.org/0000-0003-2090-3445
Wai Keung LeungDepartment of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, China.ORCID https://orcid.org/0000-0002-5993-1059
Steven F MossBrown University, Providence, Rhode Island, USA.ORCID https://orcid.org/0000-0003-3447-0388
Carlo A FalloneDivision of Gastroenterology, McGill University Health Center, Montreal, Canada.ORCID https://orcid.org/0000-0002-1686-5047
Peter KatelarisGastroenterology Department, Concord Hospital, University of Sydney, Camperdown, New South Wales, Australia.ORCID https://orcid.org/0000-0001-6969-4328
Christian SchulzMedical Department 2, LMU Hospital, Ludwig-Maximilians-University, Munich, Germany.ORCID https://orcid.org/0000-0003-1841-1337
Violet KayambaSchool of Medicine, University of Zambia, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-6521-2501
Liya ZhouDepartment of Gastroenterology, Beijing Key Laboratory of Helicobacter Pylori Infection and Upper Gastrointestinal Diseases, Peking University Third Hospital, Beijing, China.ORCID https://orcid.org/0000-0002-2064-5522
Nhu Thi Hanh VuDepartment of Internal Medicine and Gastro-Hepato Integrated Research Team (GHIRT-002.TCM2025), University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.ORCID https://orcid.org/0000-0003-4208-7813
Ratha-Korn VilaichoneCenter of Excellence in Digestive Diseases and Gastroenterology Unit, Department of Medicine and Thailand Science Research and Innovation Fundamental Fund, Thammasat University, Klong Luang, Thailand.ORCID https://orcid.org/0000-0003-4298-9331
Muhammad MiftahussururDivision of Gastroenterohepatology, Department of Internal Medicine, Faculty of Medicine, Dr. Soetomo Teaching Hospital, Universitas Airlangga, Surabaya, Indonesia.ORCID https://orcid.org/0000-0003-1415-6033
Mashiko SetshediUniversity of Cape Town, Cape Town, South Africa.ORCID https://orcid.org/0000-0002-7979-2981
Arnoldo RiquelmeDepartamento de Gastroenterologia, Facultad de Medicina, Pontificia Universidad Católica de Chile, Instituto de Medicina, Red Salud UC Christus, Santiago, Chile.ORCID https://orcid.org/0000-0002-8259-8960
Abbas YadegarFoodborne and Waterborne Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0002-2135-7581
Yeong Yeh LeeSchool of Medical Sciences, Universiti Sains Malaysia, Kota Bharu, Malaysia.ORCID https://orcid.org/0000-0002-6486-7717
Fumiaki IshibashiDigestive Disease Center, Showa Medical University Northern Yokohama Hospital, Yokohama, Japan.ORCID https://orcid.org/0000-0003-4065-7958
Hwoon-Yong JungDepartment of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1281-5859
Luiz Gonzaga CoelhoAlfa Institute of Gastroenterology, Clinics Hospital, Federal University of Minas Gerais, Belo Horizonte, Brazil.ORCID https://orcid.org/0000-0002-8721-7696
Hidekazu SuzukiDivision of Gastroenterology and Hepatology, Department of Internal Medicine, Tokai University School of Medicine, Isehara City, Japan.ORCID https://orcid.org/0000-0002-8994-6163
Yi-Chia LeeDepartments of Internal Medicine and Medical Research, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.ORCID https://orcid.org/0000-0002-8160-1216
Francis MegraudINSERM U1312 BRIC, University of Bordeaux, Bordeaux, France.ORCID https://orcid.org/0000-0002-2481-1612
Varocha MahachaiCenter of Excellence in Digestive Diseases and Gastroenterology Unit, Department of Medicine and Thailand Science Research and Innovation Fundamental Fund, Thammasat University, Klong Luang, Thailand.ORCID https://orcid.org/0000-0002-8252-7492
Kentaro SuganoJichi Medical University, Shimotsuke, Japan.ORCID https://orcid.org/0000-0002-8578-2974
Peter MalfertheinerMedical Clinic II, Ludwig Maximilian University, Munich, Germany.ORCID https://orcid.org/0000-0001-8439-9036

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite increasingly refined diagnostic strategies and regularly updated treatment guidelines, real-world outcomes of Helicobacter pylori management remain variable. Antimicrobial resistance alone does not fully explain these discrepancies, suggesting important challenges in the implementation of evidence-based care.

aimsTo identify recurring implementation-related challenges across the Helicobacter pylori care pathway and highlight priorities for improving real-world management.

methodsThis expert-informed review integrated relevant literature, international guideline documents, and structured international expert prioritisation. An initial list of implementation-related pitfalls was developed through literature review, clinical experience, and discussions among the coordinating authors and selected co-authors. Twenty-six experts from five continents participated in a structured consultation process and rated predefined pitfalls using a 5-point Likert scale. Median scores were used for relative prioritisation.

resultsTreatment selection and patient management emerged as the domains most consistently prioritised by participating experts. High-impact pitfalls included empirical triple therapy in high-resistance settings, inadequate patient counselling, and empirical retreatment without escalation. Additional challenges were identified across diagnostic, treatment, and follow-up domains, highlighting persistent implementation-related barriers throughout the care pathway.

conclusionsRecurring implementation-related challenges remain important barriers to optimal Helicobacter pylori management. Structured expert prioritisation highlights potential targets for improvement and supports further research and implementation-focused strategies to improve delivery of care.

Indexed as

Anti-Bacterial AgentsHelicobacter InfectionsHelicobacter pyloriDrug Resistance, BacterialDrug Therapy, CombinationHumansPractice Guidelines as TopicAnti-Bacterial Agentsantimicrobial stewardshipclinical practicedrug resistanceHelicobacter pyloriimplementation gaps

Identifiers

PMID42310251
PMCPMC13356292

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.